We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco
Read MoreHide Full Article
For Immediate Releases
Chicago, IL – November 15, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include including Philip Morris International Inc. (PM - Free Report) , Altria Group, Inc. (MO - Free Report) and British American Tobacco p.l.c. (BTI - Free Report) .
Here are highlights from Friday’s Analyst Blog:
3 Tobacco Stocks to Watch as Smoke-Free Trends Ignite Growth
The Zacks Tobacco industry players are increasingly pivoting toward smoke-free alternatives, driven by consumer health awareness and tightening regulations against traditional cigarettes. Companies like Philip Morris International Inc., Altria Group, Inc. and British American Tobacco p.l.c. are investing significantly in reduced-risk products (RRPs), positioning them for growth in this transforming market.
Despite declining cigarette sales volumes due to inflation and changing consumer preferences, the industry benefits from robust pricing power, as smokers are typically less sensitive to price increases. This strategic shift toward RRPs, alongside resilient pricing, supports a more adaptable and sustainable industry outlook amid evolving regulatory landscapes.
About the Industry
The Zacks Tobacco industry includes companies that manufacture and sell cigarettes as well as tobacco and nicotine-based products, such as cigars, snuffs and oral tobacco. Some companies also offer RRPs, such as e-cigarettes, vaping and heat-not-burn variants. A few of the firms are engaged in making devices and attachments needed in vaping and heat-not-burn products.
Most products manufactured by the tobacco industry participants fall under the strict vigilance of the U.S. Food and Drug Administration (“FDA”) and are required to follow the permissible levels of nicotine in manufacturing. Players in this space sell products mostly through large retailers, distributors, convenience stores, drugstores, wholesalers and grocery chains. Some international tobacco firms also operate in the country through subsidiaries.
3 Trends Shaping the Future of the Tobacco Industry
Rising Popularity of Smoke-Free Options: Increased awareness of smoking-related health risks and stricter government policies aimed at reducing cigarette consumption have led more consumers to switch to reduced-risk products (RRPs) or smoke-free alternatives, such as heated tobacco, vapor, and oral nicotine options. These products, marketed as less harmful due to their scientific formulations and alternative consumption methods, are steadily gaining traction.
Many consumers are choosing these options as a way to quit traditional cigarettes. Key tobacco companies are dedicating significant resources to expanding their footprint in this category, including investments in innovations that enhance user-friendliness and energy efficiency.
As a result, companies have reported substantial revenue growth from RRPs and smoke-free products. Both Philip Morris and British American Tobacco are actively moving toward a predominantly smoke-free business model, and the continued demand for these products is expected to support positive growth as the industry undergoes transformation.
Pricing Power: Tobacco companies have capitalized on the pricing strength of traditional products, helping offset declining cigarette sales volumes. Due to the addictive nature of cigarettes, consumers are typically less sensitive to price increases, making this a viable strategy for revenue growth. Strategic pricing of cigarettes has bolstered revenues for industry players despite the ongoing drop in sales volumes.
Challenges in Cigarette Sales Volumes: The tobacco industry faces challenges from inflation, which has impacted consumer spending behavior. Economic pressures, including inflation and changing purchasing patterns among adult tobacco consumers, as well as shifts to smoke-free products, have contributed to reduced cigarette sales volumes.
Regulatory restrictions on sales, advertising and manufacturing — driven by concerns over the health risks of nicotine — have also affected volumes. Given that traditional cigarette sales still account for a significant portion of revenues in the tobacco industry, declining volumes in this category present notable concerns for companies.
Zacks Industry Rank Indicates Robust Prospects
The Zacks Tobacco industry is housed within the broader Zacks Consumer Staples sector. The industry currently carries a Zacks Industry Rank #44, which places it in the top 18% of more than 250 Zacks industries.
The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bright near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
The industry’s position in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s earnings growth potential. Since the beginning of October 2024, the industry’s earnings estimate for 2024 has risen 0.8%.
Let’s take a look at the industry’s performance and current valuation.
Industry vs. Broader Market
The Zacks Tobacco industry has underperformed the Zacks S&P 500 composite while outperforming the broader Zacks Consumer Staple sector over the past year.
The industry has gained 29.1% over this period compared with the broader sector’s growth of 5.5%. Meanwhile, the S&P 500 has risen 33.4% in the said time frame.
Industry's Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing consumer staple stocks, the industry is currently trading at 11.88X compared with the S&P 500’s 22.63X and the sector’s 17.28X.
Over the past five years, the industry has traded as high as 12.65X, as low as 9.1X and at the median of 10.68X.
3 Tobacco Stocks to Keep a Close Eye On
Philip Morris International: The company has bolstered its market standing by focusing on smoke-free products, a move that resonates with shifting consumer trends. Philip Morris is advancing toward its goal of transforming into a primarily smoke-free company by 2030.
The impressive growth of its premium smoke-free brands, IQOS and ZYN, is a key driver behind the success of its smoke-free product lineup. The Zacks Rank #2 (Buy) company also benefits from its effective pricing strategies. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for PM’s 2024 and 2025 earnings per share (EPS) has increased from $6.42 to $6.51 and from $7.09 to $7.21, respectively, in the past 30 days. The consensus marks suggest respective growth of 8.3% and 10.7% year over year. Shares of Philip Morris have rallied 24.5% in the past six months.
Altria Group: The company has been navigating market uncertainties with the support of its pricing power and focus on smoke-free products. Altria’s journey toward a smoke-free environment has been an upside. The company’s investment in on! is showing promising results, and the acquisition of NJOY Holdings marks a significant advancement in the e-vapor category. Altria’s progress in smoke-free initiatives, coupled with the strength of its traditional tobacco business, such as the Marlboro brand, positions the Zacks Rank #3 (Hold) company for growth.
Shares of MO have rallied 20.5% in the past six months. The Zacks Consensus Estimate for 2024 and 2025 EPS has remained unchanged at $5.11 and $5.30, respectively, over the past 30 days. The consensus estimates suggest respective growth of 3.2% and 3.8% year over year.
British American Tobacco: The company is strategically focused on transforming into a smoke-free business, aiming to generate more than 50% of its revenues from non-combustible products by 2035. This transformation leverages BTI’s robust multi-category approach, which includes heated tobacco, vapor and modern oral products, targeting a growing global demand for lower-risk nicotine options.
British American Tobacco is enhancing operational efficiency and cash generation, supported by innovative products and a streamlined portfolio. These strategic initiatives, along with improved commercial performance in key markets like the United States, position the Zacks Rank #3 company to sustain long-term growth while managing regulatory and competitive challenges.
The Zacks Consensus Estimate for British American Tobacco’s 2024 and 2025 bottom line has remained unchanged at $4.64 and $4.80, respectively, over the past 30 days. Shares of BTI have jumped 13.1% in the past six months.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Image: Bigstock
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco
For Immediate Releases
Chicago, IL – November 15, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include including Philip Morris International Inc. (PM - Free Report) , Altria Group, Inc. (MO - Free Report) and British American Tobacco p.l.c. (BTI - Free Report) .
Here are highlights from Friday’s Analyst Blog:
3 Tobacco Stocks to Watch as Smoke-Free Trends Ignite Growth
The Zacks Tobacco industry players are increasingly pivoting toward smoke-free alternatives, driven by consumer health awareness and tightening regulations against traditional cigarettes. Companies like Philip Morris International Inc., Altria Group, Inc. and British American Tobacco p.l.c. are investing significantly in reduced-risk products (RRPs), positioning them for growth in this transforming market.
Despite declining cigarette sales volumes due to inflation and changing consumer preferences, the industry benefits from robust pricing power, as smokers are typically less sensitive to price increases. This strategic shift toward RRPs, alongside resilient pricing, supports a more adaptable and sustainable industry outlook amid evolving regulatory landscapes.
About the Industry
The Zacks Tobacco industry includes companies that manufacture and sell cigarettes as well as tobacco and nicotine-based products, such as cigars, snuffs and oral tobacco. Some companies also offer RRPs, such as e-cigarettes, vaping and heat-not-burn variants. A few of the firms are engaged in making devices and attachments needed in vaping and heat-not-burn products.
Most products manufactured by the tobacco industry participants fall under the strict vigilance of the U.S. Food and Drug Administration (“FDA”) and are required to follow the permissible levels of nicotine in manufacturing. Players in this space sell products mostly through large retailers, distributors, convenience stores, drugstores, wholesalers and grocery chains. Some international tobacco firms also operate in the country through subsidiaries.
3 Trends Shaping the Future of the Tobacco Industry
Rising Popularity of Smoke-Free Options: Increased awareness of smoking-related health risks and stricter government policies aimed at reducing cigarette consumption have led more consumers to switch to reduced-risk products (RRPs) or smoke-free alternatives, such as heated tobacco, vapor, and oral nicotine options. These products, marketed as less harmful due to their scientific formulations and alternative consumption methods, are steadily gaining traction.
Many consumers are choosing these options as a way to quit traditional cigarettes. Key tobacco companies are dedicating significant resources to expanding their footprint in this category, including investments in innovations that enhance user-friendliness and energy efficiency.
As a result, companies have reported substantial revenue growth from RRPs and smoke-free products. Both Philip Morris and British American Tobacco are actively moving toward a predominantly smoke-free business model, and the continued demand for these products is expected to support positive growth as the industry undergoes transformation.
Pricing Power: Tobacco companies have capitalized on the pricing strength of traditional products, helping offset declining cigarette sales volumes. Due to the addictive nature of cigarettes, consumers are typically less sensitive to price increases, making this a viable strategy for revenue growth. Strategic pricing of cigarettes has bolstered revenues for industry players despite the ongoing drop in sales volumes.
Challenges in Cigarette Sales Volumes: The tobacco industry faces challenges from inflation, which has impacted consumer spending behavior. Economic pressures, including inflation and changing purchasing patterns among adult tobacco consumers, as well as shifts to smoke-free products, have contributed to reduced cigarette sales volumes.
Regulatory restrictions on sales, advertising and manufacturing — driven by concerns over the health risks of nicotine — have also affected volumes. Given that traditional cigarette sales still account for a significant portion of revenues in the tobacco industry, declining volumes in this category present notable concerns for companies.
Zacks Industry Rank Indicates Robust Prospects
The Zacks Tobacco industry is housed within the broader Zacks Consumer Staples sector. The industry currently carries a Zacks Industry Rank #44, which places it in the top 18% of more than 250 Zacks industries.
The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates bright near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
The industry’s position in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s earnings growth potential. Since the beginning of October 2024, the industry’s earnings estimate for 2024 has risen 0.8%.
Let’s take a look at the industry’s performance and current valuation.
Industry vs. Broader Market
The Zacks Tobacco industry has underperformed the Zacks S&P 500 composite while outperforming the broader Zacks Consumer Staple sector over the past year.
The industry has gained 29.1% over this period compared with the broader sector’s growth of 5.5%. Meanwhile, the S&P 500 has risen 33.4% in the said time frame.
Industry's Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing consumer staple stocks, the industry is currently trading at 11.88X compared with the S&P 500’s 22.63X and the sector’s 17.28X.
Over the past five years, the industry has traded as high as 12.65X, as low as 9.1X and at the median of 10.68X.
3 Tobacco Stocks to Keep a Close Eye On
Philip Morris International: The company has bolstered its market standing by focusing on smoke-free products, a move that resonates with shifting consumer trends. Philip Morris is advancing toward its goal of transforming into a primarily smoke-free company by 2030.
The impressive growth of its premium smoke-free brands, IQOS and ZYN, is a key driver behind the success of its smoke-free product lineup. The Zacks Rank #2 (Buy) company also benefits from its effective pricing strategies. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for PM’s 2024 and 2025 earnings per share (EPS) has increased from $6.42 to $6.51 and from $7.09 to $7.21, respectively, in the past 30 days. The consensus marks suggest respective growth of 8.3% and 10.7% year over year. Shares of Philip Morris have rallied 24.5% in the past six months.
Altria Group: The company has been navigating market uncertainties with the support of its pricing power and focus on smoke-free products. Altria’s journey toward a smoke-free environment has been an upside. The company’s investment in on! is showing promising results, and the acquisition of NJOY Holdings marks a significant advancement in the e-vapor category. Altria’s progress in smoke-free initiatives, coupled with the strength of its traditional tobacco business, such as the Marlboro brand, positions the Zacks Rank #3 (Hold) company for growth.
Shares of MO have rallied 20.5% in the past six months. The Zacks Consensus Estimate for 2024 and 2025 EPS has remained unchanged at $5.11 and $5.30, respectively, over the past 30 days. The consensus estimates suggest respective growth of 3.2% and 3.8% year over year.
British American Tobacco: The company is strategically focused on transforming into a smoke-free business, aiming to generate more than 50% of its revenues from non-combustible products by 2035. This transformation leverages BTI’s robust multi-category approach, which includes heated tobacco, vapor and modern oral products, targeting a growing global demand for lower-risk nicotine options.
British American Tobacco is enhancing operational efficiency and cash generation, supported by innovative products and a streamlined portfolio. These strategic initiatives, along with improved commercial performance in key markets like the United States, position the Zacks Rank #3 company to sustain long-term growth while managing regulatory and competitive challenges.
The Zacks Consensus Estimate for British American Tobacco’s 2024 and 2025 bottom line has remained unchanged at $4.64 and $4.80, respectively, over the past 30 days. Shares of BTI have jumped 13.1% in the past six months.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>